The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in ...

Eledon Pharmaceuticals (NASDAQ:ELDN) used a presentation at the Leerink Partners Global Healthcare Conference to highlight ...

Best ergonomic keyboards for 2026 What to look for in an ergonomic keyboard How we tested ergonomic keyboards Other ergonomic keyboards we tested Ergonomic keyboard FAQs The Ergo K860 from Logitech ...

Tim Mulkerin is a freelance writer, editor, and social media manager who has been working in digital media and the tech world since 2016. He has a bachelor's degree in art history and is currently ...

Company announcement Herantis Pharma Plc | Company Release | March 5, 2026 at 08:00 EET Herantis Pharma releases 2H and FY 2025 report today Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herant ...

Forbes contributors publish independent expert analyses and insights. Kris Holt is a writer who covers video games and word games. This voice experience is generated by AI. Learn more. This voice ...

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in patients who have received prior systemic therapy Initiate ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

If you plan on getting involved in day trading, then having access to reliable and feature-rich charting platforms can be an essential tool. With numerous day trading chart providers available in the ...

President Donald Trump is already pursuing a new path to impose tariffs, but a long road likely remains ahead for companies seeking refunds. Though the president can impose tariffs under other ...